Impairments That Affect Correct Inhaler Use in COPD

ClinicalTrials.gov ID: NCT06135324

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT06135324. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prevalence of Impairments in Cognitive Function and Manual Dexterity in Out-patients With COPD and Associations With Correct Inhaler Techniques (INHALE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

INHALE is a one-year, multi-site observational research study funded by Viatris, with two aims: 1. Determine the prevalence of both cognitive impairment and impaired manual dexterity in stable out-patients with chronic obstructive pulmonary disease (COPD). 2. Assess the relationship of cognitive impairment and impaired manual dexterity with patient errors using current pMDIs, SMIs and/or DPIs.

Study identification

NCT ID: NCT06135324
Recruitment status: Active, not recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: COPD Foundation; Other
Enrollment: 500 participants

Conditions and interventions

Conditions

COPD

Interventions

Not listed

Eligibility (public fields only)

Age range: 60 Years to 90 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 14, 2023 (Actual)
Primary completion: Apr 30, 2025 (Actual)
Completion: Oct 31, 2025 (Estimated)
Last update posted: May 11, 2025

2023 – 2025

United States locations

U.S. sites: 9
U.S. states: 9
U.S. cities: 9

Facility	City	State	ZIP	Site status
University of Alabama at Birmingham - Lung Health Center	Birmingham	Alabama	35233	—
RUSH University	Chicago	Illinois	60612	—
Lahey Clinic, Inc.	Burlington	Massachusetts	01805	—
Midwest Chest Consultants, PC	Saint Charles	Missouri	63301	—
Valley Regional Hospital	Claremont	New Hampshire	03743	—
Atrium Health Wake Forest Baptist	Winston-Salem	North Carolina	27157	—
University of Pittsburgh Medical Center	Pittsburgh	Pennsylvania	15213	—
Erlanger Health	Chattanooga	Tennessee	37403	—
University of Texas Medical Brach at Galveston	Galveston	Texas	77555	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06135324, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 11, 2025 · Synced Nov 15, 2026